We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
-13.24%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$209M
AUM Growth
-$35.3M
Cap. Flow
-$1.17M
Cap. Flow %
-0.56%
Top 10 Hldgs %
66.45%
Holding
127
New
9
Increased
46
Reduced
44
Closed
22

Top Sells

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$2.37M
2
HCA icon
HCA Healthcare
HCA
+$803K
3
AWK icon
American Water Works
AWK
+$570K
4
PEP icon
PepsiCo
PEP
+$498K
5
MCK icon
McKesson
MCK
+$485K

Sector Composition

Rank Sector Weight
1 Technology 14.44%
2 Healthcare 13.54%
3 Consumer Staples 6.39%
4 Communication Services 5.3%
5 Industrials 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
51
HP
HPQ
$27.5B
$644K 0.31%
19,645
+736
+4% +$27K
TMO icon
52
Thermo Fisher Scientific
TMO
$219B
$640K 0.31%
1,178
+13
+1% +$7.16K
J icon
53
Jacobs Solutions
J
$17B
$629K 0.3%
+5,980
New +$669K
CF icon
54
CF Industries
CF
$17.3B
$617K 0.3%
7,197
-3,805
-35% -$370K
MMM icon
55
3M
MMM
$94.3B
$590K 0.28%
5,453
+1,137
+26% +$137K
AGCO icon
56
AGCO
AGCO
$7.2B
$555K 0.27%
5,619
+978
+21% +$122K
JPM icon
57
JPMorgan Chase
JPM
$951B
$553K 0.26%
4,914
-778
-14% -$96.4K
CL icon
58
Colgate-Palmolive
CL
$74.3B
$545K 0.26%
6,798
-1,589
-19% -$124K
CAH icon
59
Cardinal Health
CAH
$55.4B
$527K 0.25%
10,083
-5,667
-36% -$322K
BIIB icon
60
Biogen
BIIB
$30.7B
$524K 0.25%
2,567
+36
+1% +$7.36K
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$126B
$517K 0.25%
1,836
+35
+2% +$9.37K
REGN icon
62
Regeneron Pharmaceuticals
REGN
$80.7B
$499K 0.24%
844
+145
+21% +$94.3K
DGX icon
63
Quest Diagnostics
DGX
$26.3B
$496K 0.24%
3,729
-1,280
-26% -$174K
BAC icon
64
Bank of America
BAC
$442B
$479K 0.23%
15,397
-2,383
-13% -$85.8K
SYNH
65
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$446K 0.21%
6,216
+1,594
+34% +$117K
INTC icon
66
Intel
INTC
$513B
$441K 0.21%
11,788
+533
+5% +$23.1K
CI icon
67
Cigna
CI
$74.5B
$425K 0.2%
+1,614
New +$416K
K
68
DELISTED
Kellanova
K
$423K 0.2%
6,322
-2,209
-26% -$144K
COR icon
69
Cencora
COR
$61.2B
$389K 0.19%
2,751
+894
+48% +$137K
SJM icon
70
J.M. Smucker
SJM
$12.8B
$376K 0.18%
2,941
+698
+31% +$93.1K
BDX icon
71
Becton Dickinson
BDX
$48.6B
$375K 0.18%
1,520
-886
-37% -$225K
ELV icon
72
Elevance Health
ELV
$85.5B
$353K 0.17%
731
+122
+20% +$60.4K
GIS icon
73
General Mills
GIS
$19.6B
$351K 0.17%
4,655
-3,060
-40% -$214K
PNC icon
74
PNC Financial Services
PNC
$101B
$346K 0.17%
2,191
+698
+47% +$117K
HD icon
75
Home Depot
HD
$354B
$341K 0.16%
1,245
+458
+58% +$135K

Similar funds

Humankind Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Humankind Investments held 127 positions worth $209M, down 14% from $244M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Humankind Investments's Q2 2022 filing shows 9 new, 46 increased, 44 reduced and 22 closed positions. Its largest new stake was Avantor: 24,058 shares worth $748K. The largest sale was Corteva, an estimated $2.37M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Humankind Investments's largest Q2 2022 buy was Avantor: 24,058 shares worth $748K.
  • Humankind Investments added most to Procter & Gamble in Q2 2022, an estimated $1.66M increase.
  • Humankind Investments's biggest Q2 2022 reduction was Corteva, cutting an estimated $2.37M.
  • Humankind Investments fully exited Universal Health Services in Q2 2022, selling an estimated $464K.
  • Humankind Investments's ten largest holdings make up 66% of its $209M portfolio in Q2 2022.
  • Humankind Investments opened 9 new positions and closed 22 in Q2 2022.
  • Humankind Investments's portfolio value fell 14% quarter-over-quarter to $209M.

Based on Humankind Investments's 13F filing for Q2 2022, filed 5 Aug 2022.